Abbott Laboratories - Other Cashflows From Investing Activities

Abbott Laboratories's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Cashflows-From-Investing-Activities" stands at 2.20 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2024.

Abbott Laboratories's third quarter result of 0.496 Billion USD for the item "Other Cashflows From Investing Activities" represents a decrease of -1.20 percent compared to it's second quarter result.

Also, Abbott Laboratories's third quarter result of 0.496 Billion USD for the item "Other Cashflows From Investing Activities" represents a decrease of -10.79 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Abbott Laboratories's third quarter result of 2.20 Billion USD for the item "Other Cashflows From Investing Activities" represents a decrease of -2.65 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.04 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.04 Billion United States Dollars.
The 3 year change is 2.13 Billion United States Dollars.
The 5 year change is 1.74 Billion United States Dollars.
The 10 year change is 0.356 Billion United States Dollars.

The Serie's long term average value is -0.645 Billion United States Dollars. It's latest available value, on 09/30/2025, is 2.85 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2017, to it's latest available value, on 09/30/2025, is +13.31 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2015, to it's latest available value, on 09/30/2025, is -0.135 Billion.